Hologic, Inc. (VIE:HOLX)

Market Cap	14.34B
Revenue (ttm)	3.51B
Net Income (ttm)	483.79M
Shares Out	n/a
EPS (ttm)	2.13
PE Ratio	29.64
Forward PE	16.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	64.50
Previous Close	64.50
Day's Range	64.50 - 64.50
52-Week Range	46.20 - 71.50
Beta	n/a
RSI	61.21
Earnings Date	Jan 30, 2026

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 1985
• Employees: 7,070
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: HOLX

Financial Performance

In 2025, Hologic's revenue was $4.10 billion, an increase of 1.74% compared to the previous year's $4.03 billion. Earnings were $565.70 million, a decrease of -28.35%.

Financial numbers in USD